Stocks
Prothena Corporation plcPRTA
NASDAQHealthcareBiotechnology$8.59
A clinical-stage biotechnology company focused on developing therapies for diseases caused by protein misfolding and aggregation, including neurodegenerative and rare peripheral amyloid disorders. Its pipeline includes antibody-based treatments targeting conditions such as Alzheimer’s disease, Parki...
52W Range: $4.32 – $13.71
Congressional Interest in Prothena Corporation plc (PRTA)
No congressional trades have been disclosed for Prothena Corporation plc (PRTA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PRTA?
No congressional trades found for this stock.